1.
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
by Schifano, Fabrizio
Psychopharmacologia, 2010, Vol.214 (3), p.593-602
2.
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
by Hata, Aaron N
Nature medicine, 2016, Vol.22 (3), p.262-269
3.
Glucocorticoid resistance in inflammatory diseases
by Barnes, Peter J, Prof
The Lancet (British edition), 2009, Vol.373 (9678), p.1905-1917
4.
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
by Xu, Miao
Nature medicine, 2016, Vol.22 (10), p.1101-1107
5.
The Endocannabinoid System and the Brain
by MECHOULAM, Raphael
Annual review of psychology, 2013, Vol.64 (1), p.21-47
6.
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
by Foster, Daniel J
Neuron (Cambridge, Mass.), 2017, Vol.94 (3), p.431-446
7.
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation
by Zhang, Pingzhao
Nature medicine, 2017, Vol.23 (9), p.1055-1062
8.
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
by Chaudhary, Amit Kumar
Cancer letters, 2017, Vol.402, p.1-8
9.
Cardioprotection and lifespan extension by the natural polyamine spermidine
by Eisenberg, Tobias
Nature medicine, 2016, Vol.22 (12), p.1428-1438
10.
What Can We Learn From The Portuguese Decriminalization of Illicit Drugs?
by Hughes, Caitlin Elizabeth
British journal of criminology, 2010, Vol.50 (6), p.999-1022
11.
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
by Gao, Hui
Nature medicine, 2015, Vol.21 (11), p.1318-1325
12.
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
by Uthaug, M.V
Psychopharmacology, 2018, Vol.235 (10), p.2979-2989
13.
Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
by Morgand, M
Clinical microbiology and infection, 2018, Vol.24 (12), p.1339.e1-1339.e5
14.
15.
Progress and promise for the MDMA drug development program
by Feduccia, Allison A
Psychopharmacology, 2017, Vol.235 (2), p.561-571
16.
Erratum: Making individualized drugs a reality
by Schellekens, Huub
Nature biotechnology, 2017, Vol.35 (8), p.797-797
17.
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
by Malehmir, Mohsen
Nature medicine, 2019, Vol.25 (4), p.641-655
18.
Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia
by Martín-González, Elena
Psychopharmacology, 2018, Vol.235 (2), p.419-432
19.
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
by Altice, Frederick L, Prof
The Lancet (British edition), 2010, Vol.376 (9738), p.367-387
20.
Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstrea...
by Batirel, A
European journal of clinical microbiology & infectious diseases, 2014, Vol.33 (8), p.1311-1322
